New combo therapy aims to wipe out early breast cancer before surgery

This study tests whether combining the immunotherapy drug camrelizumab with chemotherapy and radiation before surgery can eliminate all signs of cancer in women with early-stage triple-negative breast cancer. About 43 women will receive the treatment for 12 weeks, then have surgery. If the cancer hasn't fully responded, they get more chemo and immunotherapy before surgery. The main goal is to see how many achieve a complete response (no cancer left in the breast or lymph nodes).